Novo Nordisk, the manufacturer of Wegovy and Ozempic, has become the largest company in Europe, with a valuation exceeding the entire GDP of Denmark. The company is reportedly responsible for almost all economic growth in its home country. Despite this success, weight-loss drugs have only reached one-eighth of the potential American market, suggesting massive future growth.

